Table 2.
Disease severity values in patients with CF and control subjects
| Variable | Patients with CF | Control Subjects | P Value |
|---|---|---|---|
| Pulmonary function | |||
| FVC, liters | 3.61 ± 1.24 | 4.54 ± 1.10 | 0.023* |
| FEV1, liters | 2.78 ± 1.01 | 3.74 ± 0.81 | 0.006* |
| FEF25–75, l/s | 2.56 ± 1.30 | 3.77 ± 0.99 | 0.007* |
| FEV1, %predicted | 75 ± 16 | 97 ± 9 | 0.001* |
| FEV1/FVC, % | 72 ± 8 | 91 ± 6 | 0.044* |
| Exercise capacity | |||
| V̇o2peak | |||
| l/min | 1.6 ± 0.5 | 2.3 ± 0.8 | 0.017* |
| ml·kg−1·min−1 | 28.4 ± 4.8 | 34.5 ± 7.0 | 0.012* |
| %predicted | 73 ± 12 | 98 ± 14 | 0.001* |
| Heart rate peak, beats/min | 160 ± 6 | 184 ± 4 | 0.003* |
| Work peak, W | 139 ± 14 | 205 ± 13 | 0.001* |
Values are means ± SD.
CF, cystic fibrosis; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; FEF25–75, forced expiratory flow at 25-75% FVC; V̇o2peak, peak O2 consumption.
Statistically significant.